Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials
| Image |  |
|---|---|
| Description | scientific article published on 01 April 2020 |
| Author/s |
author: Yutaka Fujiwara Toshio Shimizu Shigehisa Kitano Akihiko Shimomura |
| Publication date | April 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |